Uromed

UROMED is a leading German medical device company specializing in the field of urology and incontinence care. Founded in 1967, the family-owned business develops and manufactures a comprehensive portfolio of urological instruments, including catheters, ureteral stents, and drainage systems. A key innovation in their portfolio is the EMDA (Electromotive Drug Administration) system, which utilizes iontophoresis to enhance the delivery of therapeutic agents directly into the bladder wall for treating conditions such as non-muscle invasive bladder cancer and chronic cystitis. Headquartered in Oststeinbek, Germany, UROMED serves a global market through its specialized export division, UROMEDEX, and is recognized for its focus on high-quality, patient-oriented solutions for chronic urological disorders.